<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WYZ886L9</identifier><date>2015</date><creator>Dobravc Verbič, Matej</creator><creator>Mrhar, Aleš</creator><creator>Primc, Kaja</creator><relation>documents/doc/W/URN_NBN_SI_doc-WYZ886L9_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WYZ886L9_001.txt</relation><format format_type="issue">5</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 392-401</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4006769</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WYZ886L9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Citostatiki</subject><subject language_type_id="slv">farmacevtska intervencija</subject><subject language_type_id="slv">Kemoterapija</subject><subject language_type_id="slv">klinični farmacevt</subject><subject language_type_id="slv">napake</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">predpisovanje zdravil</subject><title>Evaluation of prescribing of intravenous chemotherapy to patients with gastrointestinal cancer</title><title>Vrednotenje predpisovanja intravenske kemoterapije gastroonkološkim bolnikom</title></Record>